BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3260949)

  • 21. Implications of beta-lactamase-inhibitor combinations.
    Jones RN
    J Reprod Med; 1988 Jun; 33(6 Suppl):574-8. PubMed ID: 3294402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic antibiotics for cesarean section: comparison of high- and low-risk patients for endomyometritis.
    Apuzzio JJ; Reyelt C; Pelosi M; Sen P; Louria DB
    Obstet Gynecol; 1982 Jun; 59(6):693-8. PubMed ID: 7043345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-lactamase inhibition: therapeutic advances. Proceedings of a symposium. Fort Lauderdale, Florida, March 22-23, 1985.
    Am J Med; 1985 Nov; 79(5B):1-196. PubMed ID: 3878079
    [No Abstract]   [Full Text] [Related]  

  • 24. Ticarcillin-clavulanate therapy for infections with ticarcillin-resistant microorganisms.
    Gelfand MS; Lawson RD; Baucom W
    South Med J; 1989 Apr; 82(4):433-7. PubMed ID: 2705069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ticarcillin-clavulanic acid therapy in severe infections.
    Van der Auwera P; Legrand JC
    Drugs Exp Clin Res; 1985; 11(11):805-13. PubMed ID: 3836862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ticarcillin plus clavulanic acid in the treatment of patients with cancer.
    Fainstein V; Elting L; Pitlik S; Hortobagyi G; Keating M; Bodey GP
    Am J Med; 1985 Nov; 79(5B):62-6. PubMed ID: 4073096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains].
    Shiono A; Kurihara J; Hayashi M; Suzuki T; Imai K; Yamanaka H; Takezawa Y; Kiren H; Okabe K; Tomaru Y
    Hinyokika Kiyo; 1993 Aug; 39(8):777-82. PubMed ID: 8379483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Hou F; Li J; Gao L; Chen Y
    Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic usage in pelvic infections. An overview.
    Faro S
    J Reprod Med; 1988 Jun; 33(6 Suppl):566-70. PubMed ID: 3294400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
    File TM; Tan JS
    Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
    Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of a ticarcillin-clavulanic acid combination in severe infections in adults].
    Lacut JY; Quentin C; Cardoso-Mendes I; Dupon M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):591-5. PubMed ID: 3937132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the safety and efficacy of parenteral ticarcillin/clavulanate and clindamycin/gentamicin in serious intra-abdominal infections.
    Fink MP; Helsmoortel CM; Arous EJ; Doern GV; Moriarty KP; Fairchild PG; Townsend PL
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():147-56. PubMed ID: 2691476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of single-agent antimicrobial therapy in the treatment of polymicrobial female pelvic infections.
    Faro S; Sanders CV; Aldridge KE
    Obstet Gynecol; 1982 Aug; 60(2):232-6. PubMed ID: 6760009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic therapy for pelvic inflammatory disease.
    Pastorek JG
    J Reprod Med; 1990 Mar; 35(3 Suppl):329-32. PubMed ID: 2181120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
    Croydon E; Weerts D
    Chemioterapia; 1987 Jun; 6(2 Suppl):405-7. PubMed ID: 3334585
    [No Abstract]   [Full Text] [Related]  

  • 38. A preliminary report of ticarcillin and clavulanate versus triple antibiotic therapy in children with ruptured appendicitis.
    Pokorny WJ; Kaplan SL; Mason EO
    Surg Gynecol Obstet; 1991; 172 Suppl():54-6. PubMed ID: 2024227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ticarcillin plus clavulanic acid in the treatment of pneumonia and other serious infections.
    Brittain DC; Scully BE; Neu HC
    Am J Med; 1985 Nov; 79(5B):81-3. PubMed ID: 4073099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ticarcillin plus clavulanic acid (Timentin) compared with standard antibiotic regimes in the treatment of early and late neonatal infections.
    Miall-Allen VM; Whitelaw AG; Darrell JH
    Br J Clin Pract; 1988 Jul; 42(7):273-9. PubMed ID: 3075503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.